Wang Lulu, Tian Han, Xu Xinxin, Gu Xinyan, Li Liu, Zheng Hui, Xu Jie, Dai Chunsun, Jiang Lei
Center for Kidney Disease, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Kidney Dis (Basel). 2025 Mar 6;11(1):186-193. doi: 10.1159/000544992. eCollection 2025 Jan-Dec.
Blood pressure (BP) exhibits a circadian rhythm characterized by higher levels during wakefulness and lower levels during sleep; however, the functional and structural impact of the rhythms of BP remains uncertain.
Two hundred hypertensive males aged 55 and older without overt cardiovascular or cerebrovascular diseases were enrolled in this longitudinal study. Of these, 188 were included in the analyses (12 lacked valid BP records for part of the 24-h period). Rhythmic profiling of BP was performed using ARSER, and rhythmicity was considered significant at < 0.05. Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology (CKD-EPI) formula. The primary outcome was the change in eGFR.
The average age was 64.9 ± 7.2 years. For systolic BP (SBP), 38 of the subjects exhibited a 12-h rhythm and 43 subjects a 24-h rhythm; for diastolic BP (DBP), 38 exhibited a 12-h rhythm, and 36 exhibited a 24-h rhythm. During the 3-year follow-up period, 16 of the subjects died, and 36 were lost to follow-up. The mean eGFR at baseline and follow-up were, respectively, 86.6 ± 14.0 and 81.0 ± 17.1 mL min 1.73 m ( = 0.001). The urinary albumin:creatinine ratio did not vary significantly among the groups ( = 0.059). Subjects with 12-h rhythmic SBP exhibited a smaller reduction in eGFR than those with arrhythmic SBP ( = 0.014). However, the changes in eGFR were similar among the groups displaying 12-h or 24-h rhythmic DBP or arrhythmic DBP. We defined a decline in eGFR as a reduction of >1/2 SD between baseline and follow-up. Adjusting for confounding factors (including age, smoking, alcohol consumption, diabetes mellitus, BMI, albumin levels, administration time of antihypertensive drugs, and duration of hypertension), the risk of a decline in eGFR was 70% lower in subjects with 12-h rhythmic SBP than in those with arrhythmic SBP (heart rate = 0.307 [0.108-0.874], = 0.027).
SBP with a 12-h period is a protective predictor of the decline in eGFR in hypertensive males. It is, therefore, necessary to focus on the rhythmic profiling of BP.
血压(BP)呈现出昼夜节律,其特征是清醒时血压水平较高,睡眠时血压水平较低;然而,血压节律对功能和结构的影响仍不确定。
本纵向研究纳入了200名年龄在55岁及以上、无明显心血管或脑血管疾病的男性高血压患者。其中,188名患者纳入分析(12名患者在24小时期间部分时段缺乏有效的血压记录)。使用ARSER对血压进行节律分析,节律性在P<0.05时被认为具有统计学意义。采用慢性肾脏病流行病学协作组(CKD-EPI)公式计算估算肾小球滤过率(eGFR)。主要结局是eGFR的变化。
平均年龄为64.9±7.2岁。对于收缩压(SBP),38名受试者呈现12小时节律,43名受试者呈现24小时节律;对于舒张压(DBP),38名受试者呈现12小时节律,36名受试者呈现24小时节律。在3年的随访期内,16名受试者死亡,36名受试者失访。基线和随访时的平均eGFR分别为86.6±14.0和81.0±17.1 mL·min-1·1.73 m2(P=0.001)。各组间尿白蛋白与肌酐比值无显著差异(P=0.059)。12小时节律性SBP的受试者eGFR下降幅度小于无节律性SBP的受试者(P=0.014)。然而,在呈现12小时或24小时节律性DBP或无节律性DBP的各组中,eGFR的变化相似。我们将eGFR下降定义为基线和随访之间下降>1/2标准差。在调整混杂因素(包括年龄、吸烟、饮酒、糖尿病、BMI、白蛋白水平、降压药物给药时间和高血压病程)后,12小时节律性SBP的受试者eGFR下降风险比无节律性SBP的受试者低70%(风险比=0.307[0.108-0.874],P=0.027)。
12小时周期的SBP是男性高血压患者eGFR下降的保护性预测指标。因此,有必要关注血压的节律分析。